Are new anticoagulants a safe and reasonable alternative to low molecular weight heparins?
Dr. Buller and Dr. Noble comment on their DOACs face-off that took place during the 9th ICTHIC...
AUTHORS
Simon Noble
Senior Lecturer of Palliative Medicine, Cardiff University (Cardiff, Wales), Lead clinician for Palliative Medicine, Gwent National Health Service Trust (Newport, Wales).
Dr Noble is a member of international committees (ISTH Scientific subcommittee: Cancer-Associated Thrombosis, ISTH International guideline development group for Cancer-Associated Thrombosis, Global VTE Prevention Forum, International Thrombosis and Hemostasis Issues in Cancer Conference Faculty, ISTH SSC Cancer-Associated Thrombosis: Quality of Life Project Lead). He is the holder of a number of grants investigating thrombosis in lung cancer in clinical trials and the author of 68 papers in peer-reviewed journals.
Dr Noble is a member of international committees (ISTH Scientific subcommittee: Cancer-Associated Thrombosis, ISTH International guideline development group for Cancer-Associated Thrombosis, Global VTE Prevention Forum, International Thrombosis and Hemostasis Issues in Cancer Conference Faculty, ISTH SSC Cancer-Associated Thrombosis: Quality of Life Project Lead). He is the holder of a number of grants investigating thrombosis in lung cancer in clinical trials and the author of 68 papers in peer-reviewed journals.